CFTR MASTR Dx DBSADH MASTR v2_r4MASTR support alll MPS Systems_v2


Multiplicom expands its NGS product range with a MASTR kit that identifies actionable mutations in solid tumours

Niel - Belgium, March 31st, 2015 – Multiplicom N.V. announces the release of the SOMATIC 2 MASTR™ Plus kit for the detection of actionable somatic mutations in the genes EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN enabling affordable, personalized cancer treatment.

Multiplicom launches a DNA-test that identifies genetic risk for Familial Hypercholesterolemia

Niel - Belgium, March 12th, 2015 – Multiplicom N.V. announces the release of a DNA-test identifying the genetic risk for Familial Hypercholesterolemia, a common cause of premature coronary heart disease. On average one in 500 persons is affected worldwide. Early identification can save lives in high-risk families and rapidly excludes non-affected family members from costly clinical surveillance programs.